GlassScriptPhysician profile
Van H Nguyen
NPI 1821164880
$741.72
in general payments reported to CMS, 2019-2025
11 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.72 · 2022: $31.62 · 2023: $97.32 · 2024: $223 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $162.02 | 2022-2025 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $117.52 | 2024 | Rexulti |
| Acadia Pharmaceuticals INC | $116.08 | 2025 | Nuplazid |
| Collegium Pharmaceutical, INC. | $84.74 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $84.57 | 2022-2025 | |
| Ars Pharmaceuticals Operations, INC. | $54.27 | 2025 | Neffy |
| Pfizer INC. | $36.14 | 2021-2024 | |
| Alk-Abello, INC | $30.37 | 2025 | Odactra, Ragwitek, Grastek |
| Astrazeneca Pharmaceuticals LP | $23.66 | 2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $18.51 | 2025 | Vaxneuvance, M-M-R II, Vaxelis |
| Lnhc, INC | $13.84 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.